Consensus Rating1
Market Perform
Highest Price Target1
$5.00
Lowest Price Target1
$5.00
Consensus Price Target1
$2.50

HLS Therapeutics Stock (OTC:HLTRF), Analyst Ratings, Price Targets, Predictions

HLS Therapeutics Inc has a consensus price target of $2.5, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from Raymond James and Raymond James on March 18, 2024 and August 6, 2021. With an average price target of $2.5 between Raymond James and Raymond James, there's an implied NaN% downside for HLS Therapeutics Inc from these 2 analyst ratings.

Analyst Trend
1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Raymond James
Raymond James

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for HLS Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/18/2024HLTRFBuy Now
HLS Therapeutics
Raymond James
Rahul Sarugaser
$6.5 → $5MaintainsMarket PerformGet Alert
08/06/2021HLTRFBuy Now
HLS Therapeutics
Raymond JamesDowngradeOutperform → Market PerformGet Alert

FAQ

Q

What is the target price for HLS Therapeutics (HLTRF)?

A

The latest price target for HLS Therapeutics (OTCPK: HLTRF) was reported by Raymond James on March 18, 2024. The analyst firm set a price target for $5.00 expecting HLTRF to fall to within 12 months (a possible NaN% downside). 1 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for HLS Therapeutics (HLTRF)?

A

The latest analyst rating for HLS Therapeutics (OTCPK: HLTRF) was provided by Raymond James, and HLS Therapeutics maintained their market perform rating.

Q

When was the last upgrade for HLS Therapeutics (HLTRF)?

A

There is no last upgrade for HLS Therapeutics.

Q

When was the last downgrade for HLS Therapeutics (HLTRF)?

A

The last downgrade for HLS Therapeutics Inc happened on August 6, 2021 when Raymond James changed their price target from N/A to N/A for HLS Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for HLS Therapeutics (HLTRF)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HLS Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HLS Therapeutics was filed on March 18, 2024 so you should expect the next rating to be made available sometime around March 18, 2025.

Q

Is the Analyst Rating HLS Therapeutics (HLTRF) correct?

A

While ratings are subjective and will change, the latest HLS Therapeutics (HLTRF) rating was a maintained with a price target of $6.50 to $5.00. The current price HLS Therapeutics (HLTRF) is trading at is $undefined, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.